Go Pro

MarketBeat Instant News Alerts

FocalTherics (NASDAQ:FOCL) Receives Average Rating of "Hold" from Brokerages

FocalTherics (NASDAQ:FOCL - Get Free Report) has been assigned a consensus rating of "Hold" from the five research firms that are covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation, one

NASDAQ:FOCL
Read FocalTherics (NASDAQ:FOCL) Receives Average Rating of "Hold" from Brokerages
Supermarket Income REIT logo with Real Estate background

Roger Blundell Sells 50,000 Shares of Supermarket Income REIT (LON:SUPR) Stock

Supermarket Income REIT (LON:SUPR - Get Free Report) insider Roger Blundell sold 50,000 shares of Supermarket Income REIT stock in a transaction on Thursday, August 13th. The shares were sold at an average price of GBX 86, for a total transaction of £43,000.

LON:SUPR
Read Roger Blundell Sells 50,000 Shares of Supermarket Income REIT (LON:SUPR) Stock
Ligand Pharmaceuticals logo with Healthcare background

Ligand Pharmaceuticals (NASDAQ:LGND) Now Covered by Leerink Partners

Leerink Partners assumed coverage on Ligand Pharmaceuticals in a research note on Friday. They issued an "outperform" rating for the company.

NASDAQ:LGND
Read Ligand Pharmaceuticals (NASDAQ:LGND) Now Covered by Leerink Partners
Harmony Biosciences logo with Healthcare background

Harmony Biosciences Highlights Record WAKIX Growth, Advances Orexin and Epilepsy Pipeline

Harmony Biosciences (NASDAQ:HRMY) highlighted record quarterly performance for its narcolepsy treatment WAKIX and outlined development plans across its orexin, epilepsy and pitolisant lifecycle-management programs during Piper Sandler’s virtual CNS Symposium. Peter Anastasiou, the company’s chief o

NASDAQ:HRMY
Read Harmony Biosciences Highlights Record WAKIX Growth, Advances Orexin and Epilepsy Pipeline
LanzaTech Global logo with Industrials background

LanzaTech Global Q2 Earnings Call Highlights

LanzaTech Global (NASDAQ:LNZA) reported second-quarter 2026 revenue that was broadly flat from a year earlier, while sharply lower operating expenses helped narrow its adjusted EBITDA loss as the company continues shifting from an R&D-led model toward project development and commercialization.

NASDAQ:LNZA
Read LanzaTech Global Q2 Earnings Call Highlights
ImmuCell logo with Healthcare background

ImmuCell Q2 Earnings Call Highlights

ImmuCell (NASDAQ:ICCC) reported higher second-quarter sales and earnings as domestic demand for its calf scours prevention products increased, while the company outlined plans to invest about $8 million to more than triple manufacturing capacity by the end of 2027. Product sales rose 11.5% year ove

NASDAQ:ICCC
Read ImmuCell Q2 Earnings Call Highlights

Trending News

All MarketBeat Instant News Alerts

Gemini Space Station logo with Finance background

Gemini Space Station Q2 Earnings Call Highlights

NASDAQ:GEMI
Read Gemini Space Station Q2 Earnings Call Highlights
Digi Power X logo with Technology background

Digi Power X Q2 Earnings Call Highlights

NASDAQ:DGXX
Read Digi Power X Q2 Earnings Call Highlights
AirJoule Technologies logo with Industrials background

AirJoule Technologies Q2 Earnings Call Highlights

NASDAQ:AIRJ
Read AirJoule Technologies Q2 Earnings Call Highlights
Stratec logo with Healthcare background

Stratec Q2 Earnings Call Highlights

ETR:SBS
Read Stratec Q2 Earnings Call Highlights
Aebi Schmidt logo with Industrials background

DA Davidson Issues Positive Forecast for Aebi Schmidt (NASDAQ:AEBI) Stock Price

NASDAQ:AEBI
Read DA Davidson Issues Positive Forecast for Aebi Schmidt (NASDAQ:AEBI) Stock Price
Applied Industrial Technologies logo with Industrials background

Applied Industrial Technologies (NYSE:AIT) Stock Price Expected to Rise, DA Davidson Analyst Says

NYSE:AIT
Read Applied Industrial Technologies (NYSE:AIT) Stock Price Expected to Rise, DA Davidson Analyst Says
Appian logo with Technology background

Appian (NASDAQ:APPN) Price Target Raised to $42.00

NASDAQ:APPN
Read Appian (NASDAQ:APPN) Price Target Raised to $42.00

Alliance Laundry (NYSE:ALH) Price Target Raised to $32.00 at JPMorgan Chase & Co.

NYSE:ALH
Read Alliance Laundry (NYSE:ALH) Price Target Raised to $32.00 at JPMorgan Chase & Co.
A10 Networks logo with Technology background

A10 Networks' (ATEN) Buy Rating Reiterated at BWS Financial

NYSE:ATEN
Read A10 Networks' (ATEN) Buy Rating Reiterated at BWS Financial
Birkenstock logo with Consumer Discretionary background

Guggenheim Reaffirms "Buy" Rating for Birkenstock (NYSE:BIRK)

NYSE:BIRK
Read Guggenheim Reaffirms "Buy" Rating for Birkenstock (NYSE:BIRK)
Deere & Company logo with Industrials background

Deere & Company (NYSE:DE) Given New $570.00 Price Target at JPMorgan Chase & Co.

NYSE:DE
Read Deere & Company (NYSE:DE) Given New $570.00 Price Target at JPMorgan Chase & Co.
Globant logo with Technology background

Guggenheim Lowers Globant (NYSE:GLOB) Price Target to $50.00

NYSE:GLOB
Read Guggenheim Lowers Globant (NYSE:GLOB) Price Target to $50.00
Madison Square Garden logo with Communication Services background

Madison Square Garden (NYSE:MSGS) Stock Price Expected to Rise, Guggenheim Analyst Says

NYSE:MSGS
Read Madison Square Garden (NYSE:MSGS) Stock Price Expected to Rise, Guggenheim Analyst Says
Adeia logo with Technology background

Adeia (NASDAQ:ADEA) Price Target Raised to $50.00

NASDAQ:ADEA
Read Adeia (NASDAQ:ADEA) Price Target Raised to $50.00
Applied Materials logo with Technology background

JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Applied Materials (NASDAQ:AMAT) Stock

NASDAQ:AMAT
Read JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Applied Materials (NASDAQ:AMAT) Stock

Wedbush Cuts Eikon Therapeutics (NASDAQ:EIKN) Price Target to $4.00

NASDAQ:EIKN
Read Wedbush Cuts Eikon Therapeutics (NASDAQ:EIKN) Price Target to $4.00
Promis Neurosciences logo with Healthcare background

Promis Neurosciences (NASDAQ:PMN) Stock Price Expected to Rise, Guggenheim Analyst Says

NASDAQ:PMN
Read Promis Neurosciences (NASDAQ:PMN) Stock Price Expected to Rise, Guggenheim Analyst Says
Sandisk logo with Technology background

Wedbush Reaffirms "Outperform" Rating for Sandisk (NASDAQ:SNDK)

NASDAQ:SNDK
Read Wedbush Reaffirms "Outperform" Rating for Sandisk (NASDAQ:SNDK)
Zenas BioPharma logo with Healthcare background

Zenas BioPharma's (ZBIO) Buy Rating Reaffirmed at Guggenheim

NASDAQ:ZBIO
Read Zenas BioPharma's (ZBIO) Buy Rating Reaffirmed at Guggenheim
Eton Pharmaceuticals logo with Healthcare background

Eton Pharmaceuticals (NASDAQ:ETON) Sets New 1-Year High Following Earnings Beat

NASDAQ:ETON
Read Eton Pharmaceuticals (NASDAQ:ETON) Sets New 1-Year High Following Earnings Beat
First Trust Large Cap Value AlphaDEX Fund logo with background

First Trust Large Cap Value AlphaDEX Fund (NASDAQ:FTA) Short Interest Down 62.2% in July

NASDAQ:FTA
Read First Trust Large Cap Value AlphaDEX Fund (NASDAQ:FTA) Short Interest Down 62.2% in July
CO2 Energy Transition logo with Finance background

CO2 Energy Transition Corp. (NASDAQ:NOEM) Short Interest Update

NASDAQ:NOEM
Read CO2 Energy Transition Corp. (NASDAQ:NOEM) Short Interest Update
Fate Therapeutics logo with Healthcare background

Wedbush Reaffirms "Outperform" Rating for Fate Therapeutics (NASDAQ:FATE)

NASDAQ:FATE
Read Wedbush Reaffirms "Outperform" Rating for Fate Therapeutics (NASDAQ:FATE)
Zenas BioPharma logo with Healthcare background

Zenas BioPharma's (ZBIO) Outperform Rating Reiterated at Wedbush

NASDAQ:ZBIO
Read Zenas BioPharma's (ZBIO) Outperform Rating Reiterated at Wedbush

Featured Articles and Offers

Alert Categories

All Alerts